DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

Lader M, File S. The biological basis of benzodiazepine dependence.
Psychol Med, 1987, 17:539–547.
Langtry HD, Benfield P. Zolpidem: A review of its pharmacodynamic
and pharmacokinetic properties and therapeutic potential.
Drugs, 1990, 40:291–313.
Laurijssens BE, Greenblatt DJ. Pharmacokinetic–pharmacodynamic
relationships for benzodiazepines (review). Clin
Pharmacokinet, 1996, 30:52–76.
Liu C, Weaver DR, Jin X, et al. Molecular dissection of two distinct
actions of melatonin on the suprachiasmatic circadian
clock. Neuron, 1997, 19:91–102.
Lovinger DM, Zimmerman SA, Levitin M, et al.
Trichloroethanol potentiates synaptic transmission mediated
by γ-aminobutyric acid A
receptors in hippocampal neurons.
J Pharmacol Exp Ther, 1993, 264:1097–1103.
Lüddens H, Pritchett DB, Köhler M, et al. Cerebellar GABA A
receptor selective for a behavioural alcohol antagonist. Nature,
1990, 346:648–651.
Macdonald RL, McLean MJ. Cellular bases of barbiturate and
phenytoin anticonvulsant drug action. Epilepsia, 1982,
23(Suppl 1):S7–S18.
Marszalec W, Narahashi T. Use-dependent pentobarbital block of
kainate and quisqualate currents. Brain Res, 1993, 608:7–15.
Mayer G, Wang-Weigand S, Roth-Schechter B, et al. Efficacy and
safety of 6-month nightly ramelteon administration in adults
with chronic primary insomnia. Sleep, 2009, 32: 351–360.
McKeage K, Perry CM. Propofol: A review of its use in intensive
care sedation of adults. CNS Drugs, 2003, 17:235–272.
Melton ST, Wood JM, Kirkwood CK, et al. Eszopiclone for
Insomnia. Ann Pharmacother, 2005, 39:1659–1666.
Mendelson WB. Pharmacologic alteration of the perception of
being awake or asleep. Sleep, 1993, 16:641–646.
Meyer BR. Benzodiazepines in the elderly. Med Clin North Am,
1982, 66:1017–1035.
Mitler MM. Nonselective and selective benzodiazepine receptor agonists—where
are we today? Sleep, 2000, 23(Suppl 1): S39–S47.
Monane M. Insomnia in the elderly. J Clin Psychiatry, 1992,
53(Suppl):23–28.
Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions
for insomnia: A meta-analysis of treatment efficacy.
Am J Psychiatry, 1994, 151:1172–1180.
Morselli PL. Zolpidem side effects. Lancet, 1993, 342:868–869.
National Institute of Mental Health Consensus Development
Conference. Drugs and insomnia: The use of medications to
promote sleep. JAMA, 1984, 251:2410–2414.
Nattel S, Wang ZG, Matthews C. Direct electrophysiological
actions of pentobarbital at concentrations achieved during general
anesthesia. Am J Physiol, 1990, 259:H1743–H1751.
Nierenberg AA, Adler LA, Peselow E, et al. Trazodone for
antidepressant-associated insomnia. Am J Psychiatry, 1994,
151:1069–1072.
Nino-Murcia G. Diagnosis and treatment of insomnia and risks
associated with lack of treatment. J Clin Psychiatry, 1992,
53(Suppl):43–47.
Nosjean O, Ferro M, Coge F, et al. Identification of the melatonin
binding site MT3 as the quinone reductase 2. J Biol
Chem, 2000, 275:31311–31317.
Nugent M, Artru AA, Michenfelder JD. Cerebral metabolic, vascular
and protective effects of midazolam maleate:
Comparison to diazepam. Anesthesiology, 1982, 56:172–176.
Oldenhof H, de Jong M, Steenhoek A, Janknegt R. Clinical pharmacokinetics
of midazolam in intensive care patients, a wide
interpatient variability? Clin Pharmacol Ther, 1988, 43:263–269.
Pancrazio JJ, Frazer MJ, Lynch C III. Barbiturate anesthetics
depress the resting K + conductance of myocardium. J
Pharmacol Exp Ther, 1993, 265:358–365.
Perrault G, Morel E, Sanger DJ, Zivkovic B. Lack of tolerance
and physical dependence upon repeated treatment with the
novel hypnotic zolpidem. J Pharmacol Exp Ther, 1992,
263:298–303.
Petursson H. The benzodiazepine withdrawal syndrome.
Addiction, 1994, 89:1455–1459.
Pritchett DB, Seeburg PH. γ-Aminobutyric acid A receptor α5-
subunit creates novel type II benzodiazepine receptor pharmacology.
J Neurochem, 1990, 54:1802–1804.
Reeves RR, Carter OS, Pinkofsky HB, et al. Carisoprodol
(SOMA): Abuse potential and physician unawareness. J Addict
Dis, 1999, 18:51–56.
Richardson GS, Zee PC, Wang-Weigand S, et al. Circadian
phase-shifting effects of repeated ramelteon administration in
healthy adults. J Clin Sleep Med, 2008, 4:456–461.
Robinson RW, Zwillich CW. The effect of drugs on breathing during
sleep. In, Principles and Practice of Sleep Medicine. (Kryger
MH, Roth T, Dement WC, eds.) Saunders, Philadelphia, 1989.
Roehrs T, Claiborue D, Knox M, Roth T. Effects of ethanol, diphenhydramine,
and triazolam after a nap. Neuropsychopharmacology,
1993, 9:239–245.
Rosenberg R, Caron J, Roth T, et al. An assessment of the efficacy
and safety of eszopiclone in the treatment of transient
insomnia in healthy adults. Sleep Med, 2005, 6:15–22.
Roth T, Roehrs TA. Issues in the use of benzodiazepine therapy.
J Clin Psychiatry, 1992, 53(Suppl):14–18.
Roth T, Stubbs C, Walsh JK. Ramelteon (TAK-375), a selective
MT1/MT2-receptor agonist, reduces latency to persistent sleep
in a model of transient insomnia related to a novel sleep environment.
Sleep, 2005, 28:303–307.
Rothschild AJ. Disinhibition, amnestic reactions, and other
adverse reactions secondary to triazolam: A review of the literature.
J Clin Psychiatry, 1992, 53(Suppl):69–79.
Saunders PA, Ho IK. Barbiturates and the GABA A
receptor complex.
Prog Drug Res, 1990, 34:261–286.
Sieghart W, Fuchs K, Tretter V, et al. Structure and subunit composition
of GABA A
receptors. Neurochem Int, 1999, 34: 379–385.
Spivey WH. Flumazenil and seizures: An analysis of 43 cases.
Clin Ther, 1992, 14:292–305.
Symposium (various authors). Modern hypnotics and performance.
(Nicholson A, Hippius H, Rüther E, Dunbar G, eds.)
Acta Psychiatr Scand Suppl, 1986a, 332:3–174.
Symposium (various authors). Chlormethiazole 25 years: Recent
developments and historical perspectives. (Evans JG,
Feuerlein W, Glatt MM, et al., eds.) Acta Psychiatr Scand
Suppl, 1986b, 329:1–198.
Takeda Pharmaceuticals North America. Rozerem prescribing
information. 2006.
Tanaka E. Clinically significant pharmacokinetic drug interactions
with benzodiazepines. J Clin Pharm Ther, 1999, 24:
347–355.
Trapani G, Altomare C, Liso G, et al. Propofol in anesthesia:
Mechanism of action, structure–activity relationships, and
drug delivery. Curr Med Chem, 2000, 7:249–271.
479
CHAPTER 17
HYPNOTICS AND SEDATIVES